References
- EU Science Hub. 2020 Cancer incidence and mortality in EU-27 countries. [Internet]. [cited 2021 Jan 22]. Available at: https://ec.europa.eu/jrc/en/news/2020-cancer-incidence-and-mortality-eu-27-countries
- Thomas MA, Ochoa LL, Zygmunt TM, Matesa M, Altman MB, Garcia-Ramirez JL, et al. Accelerated partial breast irradiation: a safe, effective, and convenient early breast cancer treatment option. Mo Med 2015; 112: 379-84. PMID: 26606820
- Merino T, Tran WT, Czarnota GJ. Re-irradiation for locally recurrent refractory breast cancer. Oncotarget 2015; 6: 35051-62. doi: 10.18632/onco-target.6036
- Siglin J, Champ CE, Vakhnenko Y, Anne PR, Simone NL. Radiation therapy for locally recurrent breast cancer. Int J Breast Cancer 2012; 2012: 571946. doi: 10.1155/2012/571946
- Fredriksson I, Liljegren G, Arnesson L-G, Emdin SO, Palm-Sjövall M, Fornander T, et al. Local recurrence in the breast after conservative surgery − a study of prognosis and prognostic factors in 391 women. Eur J Cancer 2002; 38: 1860-70. doi: 10.1016/s0959-8049(02)00219-8
- Alpert TE, Kuerer HM, Arthur DW, Lannin DR, Haffty BG. Ipsilateral breast tumor recurrence after breast conservation therapy: outcomes of salvage mastectomy vs. salvage breast-conserving surgery and prognostic factors for salvage breast preservation. Int J Radiat Oncol Biol Phys 2005; 63: 845-51. doi: 10.1016/j.ijrobp.2005.02.035
- Huang E, Buchholz TA, Meric F, Krishnamurthy S, Mirza NQ, Ames FC, et al. Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences. Cancer 2002; 95: 2059-67. doi: 10.1002/cncr.10952
- Bedwinek J. Natural history and management of isolated local-regional recurrence following mastectomy. Semin Radiat Oncol 1994; 4: 260-9. doi: 10.1053/SRAO00400260
- Belkacemi Y, Hanna NE, Besnard C, Majdoul S, Gligorov J. Local and regional breast cancer recurrences: salvage therapy options in the new era of molecular subtypes. Front Oncol 2018; 8: 112. doi: 10.3389/fonc.2018.00112
- Matusewicz L, Czogalla A, Sikorski AF. Attempts to use statins in cancer therapy: an update. Tumor Biol 2020; 42: 1010428320941760. doi: 10.1177/1010428320941760
- Skvortsova I, Skvortsov S, Popper BA, Haidenberger A, Saurer M, Gunkel AR, et al. Rituximab enhances radiation-triggered apoptosis in Non-Hodgkin’s lymphoma cells via caspase-dependent and-independent mechanisms. J Radiat Res 2006; 47: 183-96. doi: 10.1269/jrr.47.183
- Skvortsova I, Skvortsov S, Haidenberger A, Devries A, Nevinny-Stickel M, Saurer M, et al. Effects of paclitaxel and docetaxel on EGFR-expressing human carcinoma cells under normoxic versus hypoxic conditions in vitro. J Chemother 2004; 16: 372-80. doi: 10.1179/joc.2004.16.4.372
- Skvortsov S, Sarg B, Lindner H, Lukas P, Hilbe W, Zwierzina H, et al. Cetuximab inhibits thymidylate synthase in colorectal cells expressing epidermal growth factor receptor. Proteomics Clin Appl 2008; 2: 908-14. doi: 10.1002/prca.200780034
- Choi J, Yoon YN, Kim N, Park CS, Seol H, Park I-C, et al. Predicting radiation resistance in breast cancer with expression status of phosphorylated S6K1. Sci Rep 2020; 10: 641. doi: 10.1038/s41598-020-57496-8
- Garcia-Estevez L, Moreno-Bueno G. Updating the role of obesity and cholesterol in breast cancer. Breast Cancer Res 2019; 21: 35. doi: 10.1186/s13058-019-1124-1
- Hirata E, Sahai E. Tumor microenvironment and differential responses to therapy. Cold Spring Harb Perspect Med 2017; 7: a026781. doi: 10.1101/cshperspect.a026781
- Bjarnadottir O, Feldt M, Inasu M, Bendahl PO, Elebro K, Kimbung S, et al. Statin use, HMGCR expression, and breast cancer survival - The Malmo Diet and Cancer Study. Sci Rep 2020; 10: 558. doi: 10.1038/s41598-019-57323-9
- Arnold CR, Mangesius J, Skvortsova II, Ganswindt U. The role of cancer stem cells in radiation resistance. Front Oncol 2020; 10: 164. doi: 10.3389/fonc.2020.00164
- Steinbichler TB, Dudás J, Skvortsov S, Ganswindt U, Riechelmann H, Skvortsova I-I. Therapy resistance mediated by cancer stem cells. Semin Cancer Biol 2018; 53: 156-67. doi: 10.1016/j.semcancer.2018.11.006
- Steinbichler TB, Savic D, Dudás J, Kvitsaridze I, Skvortsov S, Riechelmann H, et al. Cancer stem cells and their unique role in metastatic spread. Semin Cancer Biol 2020; 60: 148-56. doi: 10.1016/j.semcancer.2019.09.007
- Wu QJ, Tu C, Li YY, Zhu J, Qian KQ, Li WJ, et al. Statin use and breast cancer survival and risk: a systematic review and meta-analysis. Oncotarget 2015; 6: 42988-3004. doi: 10.18632/oncotarget.5557
- Efimova E V, Ricco N, Labay E, Mauceri HJ, Flor AC, Ramamurthy A, et al. HMG-CoA reductase inhibition delays DNA repair and promotes senescence after tumor irradiation. Mol Cancer Ther 2018; 17: 407-18. doi: 10.1158/1535-7163.MCT-17-0288
- Longo J, van Leeuwen JE, Elbaz M, Branchard E, Penn LZ. Statins as anticancer agents in the era of precision medicine. Clin Cancer Res 2020; 26: 5791-800. doi: 10.1158/1078-0432.CCR-20-1967
- Kaplan-Meier Plotter. Breast cancer. [Internet]. [cited 2021 Jan 22]. Available at: https://kmplot.com/analysis/
- Ricco N, Flor A, Wolfgeher D, Efimova EV, Ramamurthy A, Appelbe OK, et al. Mevalonate pathway activity as a determinant of radiation sensitivity in head and neck cancer. Mol Oncol 2019; 13: 1927-43. doi: 10.1002/1878-0261.12535
- Wolfe AR, Debeb BG, Lacerda L, Larson R, Bambhroliya A, Huang X, et al. Simvastatin prevents triple-negative breast cancer metastasis in pre-clinical models through regulation of FOXO3a. Breast Cancer Res Treat 2015; 154: 495-508. doi: 10.1007/s10549-015-3645-3
- Wolfe AR, Woodward WA. Breast cancer stem cell correlates as predicative factors for radiation therapy. Semin Radiat Oncol 2015; 25: 251-9. doi: 10.1016/j.semradonc.2015.05.009
- Van Wyhe RD, Rahal OM, Woodward WA. Effect of statins on breast cancer recurrence and mortality: a review. Breast Cancer 2017; 9: 559-65. doi: 10.2147/BCTT.S148080
- Rahal OM, Woodward WA. Cholesterol and radiosensitivity. Curr Breast Cancer Rep 2016; 8: 32-9. doi: 10.1007/s12609-016-0202-y
- Jin Y, Xu K, Chen Q, Wang B, Pan J, Huang S, et al. Simvastatin inhibits the development of radioresistant esophageal cancer cells by increasing the radiosensitivity and reversing EMT process via the PTEN-PI3K/AKT pathway. Exp Cell Res 2018; 362: 362-9. doi: 10.1016/j.yexcr.2017.11.037
- Xie F, Liu J, Li C, Zhao Y. Simvastatin blocks TGF-β1-induced epithelial-mesenchymal transition in human prostate cancer cells. Oncol Lett 2016; 11: 3377-83. doi: 10.3892/ol.2016.4404
- Kato S, Liberona MF, Cerda-Infante J, Sánchez M, Henríquez J, Bizama C, et al. Simvastatin interferes with cancer “stem-cell” plasticity reducing metastasis in ovarian cancer. Endocr Relat Cancer 2018; 25: 821-36. doi: 10.1530/ERC-18-0132
- Ahern TP, Pedersen L, Tarp M, Cronin-Fenton DP, Garne JP, Silliman RA, et al. Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study. J Natl Cancer Inst 2011; 103: 1461-8. doi: 10.1093/jnci/djr291
- Manthravadi S, Shrestha A, Madhusudhana S. Impact of statin use on cancer recurrence and mortality in breast cancer: a systematic review and meta-analysis. Int J cancer 2016; 139: 1281-8. doi: 10.1002/ijc.30185
- Bhutia SK, Mukhopadhyay S, Sinha N, Das DN, Panda PK, Patra SK, et al. Autophagy: cancer’s friend or foe? Adv Cancer Res 2013; 118: 61-95. doi: 10.1016/B978-0-12-407173-5.00003-0